Publicacions en què col·labora amb MARTA BERGÓN SENDÍN (27)

2023

  1. Human monkeypox virus in a tertiary hospital in Madrid, Spain: An observational study of the clinical and epidemiological characteristics of 53 cases

    Experimental Dermatology, Vol. 32, Núm. 2, pp. 198-202

2022

  1. Clinical outcome and safety profile of rituximab for the treatment of Dipeptidyl peptidase 4 inhibitors-induced Bullous pemphigoid

    Experimental Dermatology

  2. Effectiveness of neoadjuvant intralesional methotrexate in cutaneous squamous cell carcinoma: A prospective cohorts study

    Dermatologic Therapy, Vol. 35, Núm. 2

  3. Knowledge and role of dermatologists in life-threatening infections: a national survey among hospital skin specialists

    Journal of the European Academy of Dermatology and Venereology

  4. Prevalence and clinical features of secondary skin lesions in septic patients with bloodstream infections

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 41, Núm. 5, pp. 779-786

2021

  1. Comet Sign in Dermatitis Due to Pyemotes Species

    Actas Dermo-Sifiliograficas, Vol. 112, Núm. 10, pp. 951-952

  2. Comet Sign in Dermatitis Due to Pyemotes Species

    Actas Dermo-Sifiliograficas

  3. Comment on «Characteristics of Oral Lesions in Patients With Hansen Disease»

    Actas Dermo-Sifiliograficas

  4. Cutaneous botryomycosis mimicking ecthyma gangrenosum in a patient treated with ibrutinib

    Annals of Hematology

  5. Defining dipeptidyl peptidase-4 inhibitors-related bullous pemphigoid: A single-centre retrospective study

    Experimental Dermatology, Vol. 30, Núm. 9, pp. 1345-1351

  6. Histopathological findings in COVID-19-induced cutaneous lesions. Clinicopathological correlation of SARS-CoV-19 dermatologic patterns: review of the literature

    Australasian Journal of Dermatology, Vol. 62, Núm. 1, pp. e98-e101

  7. Intralesional cidofovir as neoadjuvant therapy in a squamous cell carcinoma of the nail bed

    Dermatologic Therapy

  8. Neoadjuvant intralesional methotrexate in small-sized cutaneous squamous cell carcinoma: a prospective study in 84 patients

    Australasian Journal of Dermatology

  9. Skin and sepsis: contribution of dermatology to a rapid diagnosis

    Infection, Vol. 49, Núm. 4, pp. 617-629

2020

  1. Aprepitant in refractory pruritus of systemic lymphoproliferative disorders

    Journal of the European Academy of Dermatology and Venereology

  2. Cutaneous Ultrasound for Tumor Thickness Measurement in Squamous Cell Carcinoma: The Effect of Neoadjuvant Intralesional Methotrexate in 40 Patients

    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], Vol. 46, Núm. 4, pp. 530-536

  3. Exanthema and eosinophilia in COVID-19 patients: has viral infection a role in drug induced exanthemas?

    Journal of the European Academy of Dermatology and Venereology

  4. Histological findings after intralesional methotrexate treatment in cutaneous squamous cell carcinoma

    Dermatologic Therapy, Vol. 33, Núm. 6

  5. Lymphocutaneous nocardiosis successfully treated with cotrimoxazole in an immunocompetent adult: A case report

    Dermatologic Therapy

2019

  1. Neoadjuvant intralesional methotrexate in squamous cell carcinoma of the lip

    Australasian Journal of Dermatology